ZANOTTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.104
AS - Asia 1.292
EU - Europa 1.277
SA - Sud America 176
AF - Africa 31
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.886
Nazione #
US - Stati Uniti d'America 3.043
CN - Cina 440
SG - Singapore 405
PL - Polonia 367
UA - Ucraina 177
DE - Germania 175
IT - Italia 161
HK - Hong Kong 155
BR - Brasile 151
FI - Finlandia 101
VN - Vietnam 97
GB - Regno Unito 78
FR - Francia 63
TR - Turchia 42
CA - Canada 37
IE - Irlanda 34
IN - India 34
RU - Federazione Russa 34
BD - Bangladesh 27
SE - Svezia 17
ID - Indonesia 15
ES - Italia 14
IQ - Iraq 14
AR - Argentina 11
MX - Messico 11
NL - Olanda 11
ZA - Sudafrica 10
PK - Pakistan 9
CZ - Repubblica Ceca 7
KR - Corea 7
UZ - Uzbekistan 7
AT - Austria 6
BG - Bulgaria 6
JP - Giappone 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
LT - Lituania 5
SA - Arabia Saudita 5
EC - Ecuador 4
KG - Kirghizistan 4
MA - Marocco 4
NG - Nigeria 4
NI - Nicaragua 4
CL - Cile 3
CR - Costa Rica 3
KE - Kenya 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
IR - Iran 1
LU - Lussemburgo 1
LY - Libia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 5.886
Città #
Warsaw 367
Fairfield 332
Ashburn 300
Singapore 243
Woodbridge 234
Houston 175
Seattle 169
San Jose 148
Chandler 141
Hong Kong 137
Jacksonville 133
Cambridge 117
Wilmington 105
New York 103
Beijing 98
Ann Arbor 93
Dearborn 92
Los Angeles 70
Helsinki 69
The Dalles 67
Princeton 62
Nanjing 41
Brescia 40
Munich 36
Dublin 34
Istanbul 31
Shanghai 30
Lauterbourg 29
Des Moines 25
San Francisco 25
Chicago 23
Dallas 23
Council Bluffs 22
Buffalo 21
Dong Ket 20
Jinan 20
São Paulo 20
Ho Chi Minh City 19
London 19
Milan 17
Shenyang 16
Toronto 16
Santa Clara 15
Hanoi 14
Orem 14
Turku 14
Central 13
Changsha 13
Moscow 12
Nanchang 12
Hangzhou 11
Hebei 11
Rome 11
Kunming 10
Belo Horizonte 9
Chennai 9
Jiaxing 9
Redondo Beach 9
Stockholm 9
Tianjin 9
Denver 8
Jakarta 8
Paris 8
Poplar 8
San Diego 8
Ankara 7
Guangzhou 7
Boston 6
Brooklyn 6
Falkenstein 6
Lanzhou 6
Monmouth Junction 6
Montreal 6
Phoenix 6
Tashkent 6
Zhengzhou 6
Brno 5
Brussels 5
Hefei 5
Johannesburg 5
Lahore 5
Manchester 5
Mexico City 5
Mumbai 5
Norwalk 5
Sofia 5
Tokyo 5
Vienna 5
Abuja 4
Atlanta 4
Baghdad 4
Bishkek 4
Cape Town 4
Cazzago San Martino 4
Da Nang 4
Frankfurt am Main 4
Leawood 4
Managua 4
Miami 4
Milton Keynes 4
Totale 4.202
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 361
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 356
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 286
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 213
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 211
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 203
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 201
Altered immunolocalization of heat-shock proteins in human peri-implant gingiva 190
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 188
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 186
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 181
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 180
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 173
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 173
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 170
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 169
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 163
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 161
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 153
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 150
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 146
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 141
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 133
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 130
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 120
Room-temperature gas sensing based on visible photoluminescence properties of metal oxide nanobelts 118
Oxide nanobelts as conductometric gas sensors 112
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 112
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 109
Gas sensitive light emission properties of tin oxide nanobelts 108
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 97
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 95
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 72
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 50
Serum miRNA-based diagnostic models for endometriosis: from discovery to validation 13
Totale 5.975
Categoria #
all - tutte 25.688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.688


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 0 0 40
2021/2022337 43 59 5 4 1 15 24 16 11 46 43 70
2022/2023361 57 24 19 25 28 67 3 37 63 4 16 18
2023/2024457 26 11 46 33 23 111 23 36 75 26 8 39
2024/2025705 6 15 7 103 45 85 54 35 72 42 150 91
2025/20261.678 165 166 110 231 209 138 269 61 104 147 64 14
Totale 5.975